Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reinventing Cell Therapy And Biomaterials

Executive Summary

A profound redefinition of the role of many cell types and biomaterials in regenerative medicine is under way as researchers have moved away from the notion that cells introduced into the body will integrate and become functioning tissue.


Related Content

Shedding Earlier Fears, Pharma Takes A Fresh Look At Cell, Gene Therapies
Advanced Wound Care: A Future Built On Innovation
Start-Ups, Strategics Help Mend Wound Repair
Financings Of The Fortnight Expects An Increase In Life Sciences IPOs In 2013
Newly Appointed Head of Regenerative Medicine At Shire Plans Rapid Growth For The Division
In Cartilage Repair Histogenics Resets The Stage
Pervasis Buyout Increases Shire’s Expertise In Regenerative Medicine
U.K. Biotech Renovo's Future On The Line As Phase III Lead Crashes
Medtronic and Genzyme Combine Their Cell Therapy Approaches to Serious Heart Disease


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts